Mira Chaurushiya

Mira is a Partner at 5AM Ventures and invests in early stage biotechnology companies. Mira currently serves as an Observer or Member of the Boards of Enliven Therapeutics, Purigen Biosystems, Escient Pharmaceuticals, Magnetic Insight, TMRW, and Novome Biotechnologies; and was previously a Director at Precision Nanosystems (acquired by Danaher) and Observer at Ideaya Biosciences (NASDAQ: IDYA) and NodThera.

She is a Fellow of the Society of Kauffman Fellows and also serves on the Board of Biotech Connection Bay Area, a non-profit that focuses on career development for academic scientists. Mira received a Ph.D. in Biological Sciences from the University of California, San Diego in conjunction with the Salk Institute for Biological Studies, where she was awarded the Martin Kamen Thesis Prize in Biochemistry. She received her B.A. in Biology from Carleton College.